Science Explorer Interactive view Map
Company · Linhai · China

Huahai Pharmaceutical (China)

Research works
98
▼ 14% vs 2013–17
Citations
421
4.3 per fractional work
Top-10% rate
9.3%
record average 16.5%
Open access
24%
world 28%

Not ranked overall: Huahai Pharmaceutical (China) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 1.58× its world share, 2 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 5.19× its world share, 7 worksBiochemistry, Geneti…Immunology and Microbiology: 0.64× its world share, 0 worksImmunology and Micro…Pharmacology, Toxicology and Pharmaceutics: 8.27× its world share, 1 worksPharmacology, Toxico…Chemical Engineering: 6.29× its world share, 1 worksChemical EngineeringChemistry: 8.76× its world share, 4 worksChemistryComputer Science: 0.06× its world share, 0 worksComputer ScienceEarth and Planetary Sciences: 0.41× its world share, 0 worksEarth and Planetary …Energy: 0.23× its world share, 0 worksEnergyEngineering: 0.68× its world share, 3 worksEngineeringEnvironmental Science: 0.43× its world share, 0 worksEnvironmental ScienceMaterials Science: 1.12× its world share, 1 worksMaterials ScienceMathematics: 0.22× its world share, 0 worksMathematicsMedicine: 1.44× its world share, 7 worksMedicineworld share
more than its size predictsabout as predictedless

Rings at 0.5×, and 2×. Widest outward: Chemistry, 8.8×. Every wedge is a field page.

Which keywords describe research at Huahai Pharmaceutical (China)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Cancer, Transcriptional Regulation, Cell Proliferation, Epigenetic Regulation, Arginine Methylation, Protein Arginine Methyltransferases, Cancer Therapy and Biomarkers.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 14 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 14 words, with their numbers
  1. Cancer3▲ 8.8×11 topics
  2. Transcriptional Regulation2▲ 46×3 topics
  3. Cell Proliferation2▲ 76×2 topics
  4. Inflammation2▲ 3.1×10 topics
  5. Epigenetic Regulation1▲ 25×2 topics
  6. Arginine Methylation1▲ 190×1 topic
  7. Protein Arginine Methyltransferases1▲ 190×1 topic
  8. Antioxidant1▲ 6.6×7 topics
  9. Biomarkers1▲ 6.7×6 topics
  10. Cancer Therapy1▲ 8.1×5 topics
  11. Method Validation1▲ 75×2 topics
  12. Oxidative Stress1▲ 2.7×8 topics
  13. Homologous Recombination1▲ 86×2 topics
  14. Mass Spectrometry1▲ 25×3 topics

Which research topics does Huahai Pharmaceutical (China) publish most on?

By volume in 2022–2025: Cancer-related gene regulation, Prostate Cancer Treatment and Research, Analytical Methods in Pharmaceuticals and HIV/AIDS drug development and treatment.

  1. 1 Cancer-related gene regulation Molecular Biology 1 works
  2. 2 Prostate Cancer Treatment and Research Pulmonary and Respiratory Medicine 1 works
  3. 3 Analytical Methods in Pharmaceuticals Analytical Chemistry 1 works
  4. 4 HIV/AIDS drug development and treatment Infectious Diseases 0 works
  5. 5 Garlic and Onion Studies Plant Science 0 works
  6. 6 DNA Repair Mechanisms Molecular Biology 0 works
  7. 7 Structural Engineering and Vibration Analysis Civil and Structural Engineering 0 works
  8. 8 Analytical Chemistry and Sensors Bioengineering 0 works
  9. 9 Plant Physiology and Cultivation Studies Plant Science 0 works
  10. 10 PARP inhibition in cancer therapy Oncology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available23.9%not open76.1%

World: 28% of research is openly available.

with international co-authors11.7%domestic only88.3%

World: 19% is written across borders.

How has Huahai Pharmaceutical (China)'s research output changed?

Output in 2018–2022 was 14% lower than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Linhai

All research institutions in Linhai

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.